CASI Pharmaceuticals, Inc.
SEC Filing List
CASI CIK: 0001962738
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 3 | Initial statement of beneficial ownershi... | Huang Hai | Toppan Merrill/FA | 04/07/2026 | |
| 3 | Initial statement of beneficial ownershi... | Wang Chunhua | Toppan Merrill/FA | 04/03/2026 | |
| 3 | Initial statement of beneficial ownershi... | Zukiwski Alexander A | Toppan Merrill/FA | 04/03/2026 | |
| 3 | Initial statement of beneficial ownershi... | Krebs-pohl Barbara Helene Hannelore | Toppan Merrill/FA | 03/27/2026 | |
| 3 | Initial statement of beneficial ownershi... | Wu Alex | Toppan Merrill/FA | 03/25/2026 | |
| SCHEDULE 13D/A | Toppan Merrill/FA | 03/23/2026 | |||
| 3 | Initial statement of beneficial ownershi... | Huang James | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/18/2026 | |
| 3 | Initial statement of beneficial ownershi... | He Wei-wu | Toppan Merrill/FA | 03/18/2026 | |
| 6-K | Current report of foreign issuer pursuan... | Casi Pharmaceuticals, Inc. | Toppan Merrill/FA | 03/03/2026 | |
| D | Official notice of an offering of securi... | 02/26/2026 | |||
| No record found. | |||||
| Load More | |||||
